Austria could save Euros 256 million by using more generics

Journal Title: Generics and Biosimilars Initiative Journal - Year 2012, Vol 1, Issue 3

Abstract

A recent study by IMS Health Austria (IMS) revealed that in Austria healthcare payers could have saved more than a quarter billion Euros during 2011 if physicians would have prescribed more generics to their patients.

Authors and Affiliations

Christoph Baumgärtel

Keywords

Related Articles

Myths, questions, facts about generic drugs in the EU

Many generic drugs are now being prescribed and the trend is increasing. For example, in Austria, the number of all generics prescriptions has more than doubled from 11% in 2000 to 23% in 2010. However, many myths and qu...

The MEDICRIME Convention: criminalising the falsification of medicines and similar crimes

Trade in falsified/counterfeit medical products is a growing global criminal industry, posing a major threat to patients and healthcare systems. Falsified/Counterfeit medical products circulate via unregulated channels,...

New CHMP guideline on immunogenicity of monoclonal antibodies

The importance of monoclonal antibodies as a product class and the challenge of assessing unwanted immunogenicity for these products have prompted the drafting of a new CHMP (Committee for Medicinal Products for Human Us...

PMDA update: the current situation and future directions

The Pharmaceuticals and Medical Devices Agency (PMDA) is a Japanese drug regulatory agency, sharing responsibilities with the Ministry of Health, Labour and Welfare. Its mission is to protect the public health by assurin...

Understanding the components of pharmaceutical expenditure—overview of pharmaceutical policies influencing expenditure across European countries

Aim: To explain the components of pharmaceutical expenditure and illustrate the strengths and limitations of this indicator. In particular, we explore policies applied in European countries that affect the price and volu...

Download PDF file
  • EP ID EP355660
  • DOI 10.5639/gabij.2012.0103-4.038
  • Views 109
  • Downloads 0

How To Cite

Christoph Baumgärtel (2012). Austria could save Euros 256 million by using more generics. Generics and Biosimilars Initiative Journal, 1(3), 144-. https://europub.co.uk./articles/-A-355660